Open original FDA record ↗Recall record
- FDA identifier
- Z-0441-2011
- Company in FDA record
- Biosite Inc Dba Innovacon Inc.
- FDA classification date
- Nov 22, 2010
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 20, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
The recall was initiated because results were being reported as being out of range. Firm is reassigning ranges for HDL cholesterol in product.
Source facts
- Action
- All customers were notified and given instructions, requirements, and expectations for their role in the Correction activities using the Notice of Correction with attached Returned Verification Forms which were supplied via fax, email or direct mail beginning on October 6, 2010. Customers are to share the information provided in the Notice with their laboratory staff and retain the letter as part of their laboratory Quality System documentation. If any affected product had been further distributed to another laboratory, then a copy of the letter should be provided to them. Customers are to complete and fax the enclosed Verification Form within 10 days to confirm their receipt of the notice. Consignees with questions about the information contained in the notification were instructed to contact: Alere San Diego, Inc. 9975 Summers Ridge Road San Diego, CA 92121 U.S.A. Phone: 877 441 7440 FAX: 858 805 8457 E-mail: Response.ts@alere.com
- Initiated
- 2010-10-06
- Root cause
- Pending
- Terminated
- 2012-08-01
- Distribution
- Worldwide Distribution -- USA, Australia, Canada, Great Britain, India, Italy, Mexico, Norway, Puerto Rico, South Korea, Spain, Switzerland, and Trinidad & Tobago.
- Recall number
- Z-0441-2011
- Recall status
- Terminated
- CDRH record ID
- 95112
- FDA classified
- 2010-11-22
- Recall event number
- 56985